• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $AIRS

    AirSculpt Technologies Inc.

    Subscribe to $AIRS
    $AIRS
    Medical/Nursing Services
    Health Care

    AirSculpt Technologies, Inc. focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of October 5, 2021, it operated 16 centers across 13 states. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

    IPO Year: 2021

    Exchange: NASDAQ

    Website: elitebodysculpture.com

    Recent Analyst Ratings for AirSculpt Technologies Inc.

    DatePrice TargetRatingAnalyst
    10/17/2024Neutral
    BTIG Research
    5/14/2024$8.25 → $5.00Outperform → Market Perform
    Leerink Partners
    11/11/2022$4.00Overweight → Neutral
    Piper Sandler
    6/16/2022$17.00 → $8.50Overweight → Equal-Weight
    Morgan Stanley
    11/23/2021$18.00Outperform
    Raymond James
    11/23/2021$17.00Overweight
    Morgan Stanley
    11/23/2021$26.00Outperform
    SVB Leerink
    11/23/2021$22.00Overweight
    Piper Sandler
    See more ratings

    AirSculpt Technologies Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance

      MIAMI BEACH, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2025. "We began the year reporting results in line with our expectations, and while we are early in our transformation, I am encouraged by the progress the team has made on the business imperatives we set in place at the start of the year and I remain confident that we have identified and are implementing the right actions to return to growth," stated Yogi Jashnani, Chief Executive Officer. "To this end, the first quarter saw profitability

      5/2/25 6:00:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Announces First Quarter Fiscal 2025 Earnings Release Date and Conference Call

      MIAMI BEACH, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report first quarter 2025 financial results before market open on Friday, May 2, 2025, to be followed by a conference call on the same day at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13753206 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirScul

      4/25/25 6:45:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results

      MIAMI BEACH, Fla., March 14, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the fourth quarter and twelve months ended December 31, 2024. "Following a challenging 2024, I am eager to help write the next chapter for AirSculpt and focus on setting a strategy, implementing business processes and developing a culture that delivers meaningful value for our shareholders," stated Yogi Jashnani, Chief Executive Officer. "AirSculpt possesses many strengths given its proprietary method, its successful track record of providing more th

      3/14/25 6:00:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Announces Fourth Quarter Fiscal 2024 Earnings Release Date and Conference Call

      MIAMI BEACH, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report fourth quarter 2024 financial results before market open on Friday, March 14, 2025, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13751643 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Air

      3/6/25 6:45:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Updates Fiscal Year 2024 Guidance in Advance of its Participation in the ICR Conference 2025

      MIAMI BEACH, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), an industry leader and provider of premium body contouring procedures, today announced an update to its fiscal year 2024 guidance. The Company is providing this information in conjunction with participating in the ICR Conference 2025. "Last week marked my official start as CEO of AirSculpt and I am excited to utilize my experience and create the plan that maximizes the power of our brand and leverages our innovative body contouring procedures and our asset-light business model to generate consistent, long-term profitable growth," stated Yogi Jashnani,

      1/13/25 6:45:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Announces Participation in the ICR Conference 2025

      MIAMI BEACH, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), an industry leader and provider of premium body contouring procedures, today announced that it will participate in investor meetings and host a presentation at the ICR Conference 2025 being held at The Grande Lakes Orlando in Orlando, Florida on January 13, 2025 through January 14, 2025. Chief Executive Officer, Yogi Jashnani, and Chief Financial Officer, Dennis Dean, will host a presentation on Tuesday, January 14, 2025, at 10:00 a.m. Eastern Standard Time. The presentation will be webcast live at https://investors.airsculpt.com. An archive of the webcast presen

      1/7/25 6:45:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Names Yogi Jashnani Chief Executive Officer

      MIAMI BEACH, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), an industry leader and provider of premium body contouring procedures, today announced the appointment of Yogi Jashnani as Chief Executive Officer ("CEO") and a member of the Board of Directors. He succeeds Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer who will continue as Chief Financial Officer, all effective January 7, 2025. A highly-talented, results oriented executive with an accomplished career spanning more than two decades, Mr. Jashnani has architected successful transformations for public and private companies in the aesthetics

      12/17/24 6:45:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt® Technologies, Inc. Announces Opening of Its New White Plains, NY Center

      MIAMI BEACH, Fla., Dec. 2, 2024 /PRNewswire/ -- AirSculpt® Technologies, Inc., ("AirSculpt") (NASDAQ:AIRS, )) an industry leader and provider of premium body contouring procedures, today announced the opening of its White Plains body contouring center at One North Broadway Unit 111, White Plains, NY 10601, increasing its clinic count to 32 locations. The center has been thoughtfully designed and includes three operating rooms, enabling simultaneous procedures.  Also, the company's popular AirSculpt®+ skin tightening procedure has been brought to the clinic's list of offerings.

      12/2/24 1:22:00 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Reports Third Quarter Fiscal 2024 Results

      MIAMI BEACH, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the third quarter and nine months ended September 30, 2024. "Our revenue and Adjusted EBITDA for the quarter were in line with our expectations with the period including progress on our strategy despite continued challenges in the consumer environment," said Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer of AirSculpt Technologies, Inc. "We are pleased with our four new center openings during the quarter and our 2023 de novo class continues to surpass ou

      11/8/24 6:00:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Announces Preliminary Third Quarter 2024 Revenue Results

      Expects 2024 Revenue in the Range of $183 Million to $189 Million Announces Third Quarter Fiscal 2024 Earnings Date and Conference Call MIAMI BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced selected unaudited preliminary financial results for its third quarter ended September 30, 2024. For the third quarter, revenue is expected to be approximately $42.5 million, a decrease of approximately 9% over the prior year. Same store cases declined 8.1% over the prior year period. "While we continue to see top line pressures primarily from macro-econo

      10/24/24 6:30:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care

    AirSculpt Technologies Inc. Leadership Updates

    Live Leadership Updates

    See more
    • AirSculpt Technologies Names Yogi Jashnani Chief Executive Officer

      MIAMI BEACH, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), an industry leader and provider of premium body contouring procedures, today announced the appointment of Yogi Jashnani as Chief Executive Officer ("CEO") and a member of the Board of Directors. He succeeds Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer who will continue as Chief Financial Officer, all effective January 7, 2025. A highly-talented, results oriented executive with an accomplished career spanning more than two decades, Mr. Jashnani has architected successful transformations for public and private companies in the aesthetics

      12/17/24 6:45:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care

    AirSculpt Technologies Inc. Financials

    Live finance-specific insights

    See more

    AirSculpt Technologies Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    AirSculpt Technologies Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    AirSculpt Technologies Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    AirSculpt Technologies Inc. SEC Filings

    See more

    AirSculpt Technologies Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance

      MIAMI BEACH, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2025. "We began the year reporting results in line with our expectations, and while we are early in our transformation, I am encouraged by the progress the team has made on the business imperatives we set in place at the start of the year and I remain confident that we have identified and are implementing the right actions to return to growth," stated Yogi Jashnani, Chief Executive Officer. "To this end, the first quarter saw profitability

      5/2/25 6:00:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Announces First Quarter Fiscal 2025 Earnings Release Date and Conference Call

      MIAMI BEACH, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report first quarter 2025 financial results before market open on Friday, May 2, 2025, to be followed by a conference call on the same day at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13753206 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirScul

      4/25/25 6:45:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results

      MIAMI BEACH, Fla., March 14, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the fourth quarter and twelve months ended December 31, 2024. "Following a challenging 2024, I am eager to help write the next chapter for AirSculpt and focus on setting a strategy, implementing business processes and developing a culture that delivers meaningful value for our shareholders," stated Yogi Jashnani, Chief Executive Officer. "AirSculpt possesses many strengths given its proprietary method, its successful track record of providing more th

      3/14/25 6:00:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Announces Fourth Quarter Fiscal 2024 Earnings Release Date and Conference Call

      MIAMI BEACH, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report fourth quarter 2024 financial results before market open on Friday, March 14, 2025, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13751643 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Air

      3/6/25 6:45:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Updates Fiscal Year 2024 Guidance in Advance of its Participation in the ICR Conference 2025

      MIAMI BEACH, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), an industry leader and provider of premium body contouring procedures, today announced an update to its fiscal year 2024 guidance. The Company is providing this information in conjunction with participating in the ICR Conference 2025. "Last week marked my official start as CEO of AirSculpt and I am excited to utilize my experience and create the plan that maximizes the power of our brand and leverages our innovative body contouring procedures and our asset-light business model to generate consistent, long-term profitable growth," stated Yogi Jashnani,

      1/13/25 6:45:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Reports Third Quarter Fiscal 2024 Results

      MIAMI BEACH, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the third quarter and nine months ended September 30, 2024. "Our revenue and Adjusted EBITDA for the quarter were in line with our expectations with the period including progress on our strategy despite continued challenges in the consumer environment," said Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer of AirSculpt Technologies, Inc. "We are pleased with our four new center openings during the quarter and our 2023 de novo class continues to surpass ou

      11/8/24 6:00:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Announces Preliminary Third Quarter 2024 Revenue Results

      Expects 2024 Revenue in the Range of $183 Million to $189 Million Announces Third Quarter Fiscal 2024 Earnings Date and Conference Call MIAMI BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced selected unaudited preliminary financial results for its third quarter ended September 30, 2024. For the third quarter, revenue is expected to be approximately $42.5 million, a decrease of approximately 9% over the prior year. Same store cases declined 8.1% over the prior year period. "While we continue to see top line pressures primarily from macro-econo

      10/24/24 6:30:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Reports Second Quarter Fiscal 2024 Results

      Second Quarter Revenue of $51.0 million, Net Loss of $3.2 million and Adjusted EBITDA of $6.9 million Company Revises 2024 Guidance MIAMI, Aug. 09, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the second quarter and first six months ended June 30, 2024. The Company also announced that Dennis Dean, Chief Financial Officer of the Company has assumed the position of Interim Chief Executive Officer as Todd Magazine has resigned from the Chief Executive Officer role and as a member of the Board of Directors. Mr. Magazine

      8/9/24 6:10:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Announces Second Quarter Fiscal 2024 Earnings Release Date and Conference Call

      MIAMI BEACH, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS), a national provider of premium body contouring procedures, today announced it will report second quarter 2024 financial results before market open on Friday, August 9, 2024, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13747871 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirSculpt Techn

      7/25/24 6:45:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Reports for First Quarter Earnings

      MIAMI BEACH, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2024. First Quarter Cases increased 2.9% over the prior year period to 3,746Revenue increased 3.9% over the prior year to $47.6 millionNet income of $6.0 million for the quarter compared to $(0.0) million in the prior year periodDiluted income per share for the quarter of $0.10Six planned openings in 2024 "We grew revenues about 4% in the quarter driven by the de novo locations we opened in the prior year. These centers continue to outpace our

      5/10/24 6:00:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • BTIG Research initiated coverage on AirSculpt Technologies

      BTIG Research initiated coverage of AirSculpt Technologies with a rating of Neutral

      10/17/24 7:13:51 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies downgraded by Leerink Partners with a new price target

      Leerink Partners downgraded AirSculpt Technologies from Outperform to Market Perform and set a new price target of $5.00 from $8.25 previously

      5/14/24 7:53:44 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded AirSculpt Technologies from Overweight to Neutral and set a new price target of $4.00

      11/11/22 3:44:11 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded AirSculpt Technologies from Overweight to Equal-Weight and set a new price target of $8.50 from $17.00 previously

      6/16/22 7:17:16 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Raymond James initiated coverage on AirSculpt Technologies with a new price target

      Raymond James initiated coverage of AirSculpt Technologies with a rating of Outperform and set a new price target of $18.00

      11/23/21 6:55:03 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Morgan Stanley initiated coverage on AirSculpt Technologies with a new price target

      Morgan Stanley initiated coverage of AirSculpt Technologies with a rating of Overweight and set a new price target of $17.00

      11/23/21 6:53:14 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SVB Leerink initiated coverage on AirSculpt Technologies with a new price target

      SVB Leerink initiated coverage of AirSculpt Technologies with a rating of Outperform and set a new price target of $26.00

      11/23/21 6:17:08 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Piper Sandler initiated coverage on AirSculpt Technologies with a new price target

      Piper Sandler initiated coverage of AirSculpt Technologies with a rating of Overweight and set a new price target of $22.00

      11/23/21 5:15:18 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Executive Chairman Rollins Aaron bought $7,629 worth of shares (2,118 units at $3.60), increasing direct ownership by 0.01% to 15,146,039 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      5/20/25 4:11:19 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Director Chu Caroline was granted 58,594 shares, increasing direct ownership by 50% to 176,780 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      5/8/25 7:55:44 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Director Aaron Thomas J was granted 58,594 shares, increasing direct ownership by 50% to 176,580 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      5/8/25 7:54:38 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Director Higgins Kenneth was granted 58,594 shares, increasing direct ownership by 51% to 173,780 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      5/8/25 7:53:22 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Jashnani Yogesh bought $18,532 worth of shares (7,000 units at $2.65), increasing direct ownership by 2% to 464,879 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      5/7/25 5:56:15 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Jashnani Yogesh was granted 292,589 shares, increasing direct ownership by 177% to 457,879 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      3/20/25 8:16:14 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Executive Chairman Rollins Aaron was granted 157,232 shares, increasing direct ownership by 1% to 15,143,921 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      3/20/25 8:14:29 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Chief Financial Officer Dean Dennis was granted 78,616 shares, increasing direct ownership by 14% to 660,668 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      3/20/25 8:13:17 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Chief Accounting Officer Bodie Philip was granted 25,550 shares, increasing direct ownership by 51% to 76,052 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      3/20/25 8:12:31 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Jashnani Yogesh was granted 165,290 shares (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      1/8/25 8:08:22 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by AirSculpt Technologies Inc.

      SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)

      11/8/24 8:42:05 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by AirSculpt Technologies Inc. (Amendment)

      SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)

      2/14/24 1:11:48 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by AirSculpt Technologies Inc.

      SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)

      4/27/23 9:49:49 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by AirSculpt Technologies Inc. (Amendment)

      SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Filed by)

      2/14/23 3:54:52 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by AirSculpt Technologies Inc.

      SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)

      2/14/23 1:55:50 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by AirSculpt Technologies Inc. (Amendment)

      SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)

      2/13/23 3:44:51 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by AirSculpt Technologies Inc.

      SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)

      2/11/22 5:27:11 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by AirSculpt Technologies Inc.

      SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)

      2/11/22 4:28:48 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)

      5/8/25 1:47:52 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by AirSculpt Technologies Inc.

      10-Q - Airsculpt Technologies, Inc. (0001870940) (Filer)

      5/2/25 3:16:25 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)

      5/2/25 6:01:26 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form DEFA14A filed by AirSculpt Technologies Inc.

      DEFA14A - Airsculpt Technologies, Inc. (0001870940) (Filer)

      3/28/25 2:40:12 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form DEF 14A filed by AirSculpt Technologies Inc.

      DEF 14A - Airsculpt Technologies, Inc. (0001870940) (Filer)

      3/28/25 2:39:13 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form EFFECT filed by AirSculpt Technologies Inc.

      EFFECT - Airsculpt Technologies, Inc. (0001870940) (Filer)

      3/25/25 12:15:13 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form S-3 filed by AirSculpt Technologies Inc.

      S-3 - Airsculpt Technologies, Inc. (0001870940) (Filer)

      3/14/25 4:19:36 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form 10-K filed by AirSculpt Technologies Inc.

      10-K - Airsculpt Technologies, Inc. (0001870940) (Filer)

      3/14/25 2:22:03 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)

      3/14/25 6:02:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)

      1/13/25 6:52:12 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Executive Chairman Rollins Aaron bought $7,629 worth of shares (2,118 units at $3.60), increasing direct ownership by 0.01% to 15,146,039 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      5/20/25 4:11:19 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Jashnani Yogesh bought $18,532 worth of shares (7,000 units at $2.65), increasing direct ownership by 2% to 464,879 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      5/7/25 5:56:15 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care